WallStSmart

Churchill Capital Corp XI (CCXI)vsGSR IV Acquisition Corp. Class A ordinary share (GSRF)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

GSRF leads profitability with a 0.0% profit margin vs 0.0%. GSRF earns a higher WallStSmart Score of 32/100 (F).

CCXI

Avoid

23

out of 100

Grade: F

Growth: 4.3Profit: 3.5Value: 5.0Quality: 4.0
Piotroski: 2/9

GSRF

Avoid

32

out of 100

Grade: F

Growth: 4.3Profit: 3.5Value: 4.7Quality: 6.5
Piotroski: 4/9

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCXI0 strengths · Avg: 0/10

No standout strengths identified

GSRF0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CCXI4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$746.38M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

GSRF4 concerns · Avg: 3.8/10
P/E RatioValuation
35.2x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$300.52M3/10

Smaller company, higher risk/reward

Comparative Analysis Report

WallStSmart Research

Bull Case : CCXI

CCXI has a balanced fundamental profile.

Bull Case : GSRF

GSRF has a balanced fundamental profile.

Bear Case : CCXI

The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.

Bear Case : GSRF

The primary concerns for GSRF are P/E Ratio, Revenue Growth, EPS Growth.

Key Dynamics to Monitor

GSRF is growing revenue faster at 0.0% — sustainability is the question.

CCXI generates stronger free cash flow (-157,581), providing more financial flexibility.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

GSRF scores higher overall (32/100 vs 23/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Churchill Capital Corp XI

FINANCIAL SERVICES · SHELL COMPANIES · USA

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.

GSR IV Acquisition Corp. Class A ordinary share

FINANCIAL SERVICES · SHELL COMPANIES · USA

GSR IV Acquisition Corp. The company is headquartered in Austin, Texas.

Want to dig deeper into these stocks?